People · Operator

David Bryant

Named in public records as an officer, director or promoter · active 2010–2023 · Manufacturing

2
Companies
2
Filings
$3.6M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Glutenfreeda Foods IncManufacturingSeed$2.6M$6.7M2010
Valaurum, Inc.ManufacturingSeed$1.0M$4.8M2023
Operator network

David Bryant at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Daniel Cunningham · 5 companies · 1 sharedDaniel CunninghamDouglas MacKinnon · 1 companies · 1 sharedDouglas MacKinnonJessica Hale · 1 companies · 1 sharedJessica HaleMichael Pigott · 1 companies · 1 sharedMichael PigottYvonne Gifford · 1 companies · 1 sharedYvonne GiffordJames Wishart · 2 companies · 1 sharedJames WishartAdam Crum · 1 companies · 1 sharedAdam CrumAdam Trexler · 1 companies · 1 sharedAdam TrexlerAlison Backus · 1 companies · 1 sharedAlison BackusBalazs Csaki · 1 companies · 1 sharedBalazs CsakiHenry Philcox · 1 companies · 1 sharedHenry PhilcoxJohn Mitnick · 1 companies · 1 sharedJohn MitnickLee Minshull · 1 companies · 1 sharedLee MinshullPeter Illig · 1 companies · 1 sharedPeter IlligGlutenfreeda Foods Inc · $2.6M raisedGlutenfreeda Foods IncValaurum, Inc. · $1.0M raisedValaurum, Inc.David BryantDB
David Bryant Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside David Bryant on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Daniel Cunningham15
James Wishart12
Lee Minshull11
Peter Illig11
Alison Backus11
Henry Philcox11
Balazs Csaki11
Adam Crum11
John Mitnick11
Douglas MacKinnon11
Michael Pigott11
Jessica Hale11
Yvonne Gifford11
Adam Trexler11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.